Celldex Therapeutics (CLDX) PT Raised to $80 at H.C. Wainwright

November 6, 2023 10:10 AM EST Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $80.00 (from $73.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login